Topics

Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative

01:41 EDT 11 Sep 2019 | Bio-Medicine

BASEL, Switzerland (PRWEB) September 11, 2019 Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced Orion Pharma, a globally operating Finnish pharmaceutical company, has licensed Genedata Biologics® to support their R&D in the...

Original Article: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative

NEXT ARTICLE

More From BioPortfolio on "Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative"

Quick Search

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...